Share this article
Share this article
ST. PETERSBURG, Fla., June 3, 2021 /PRNewswire/ Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLE) (the Company ) announced today announced that on May 28, 2021 it received a notice ( Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market ( Nasdaq ) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the Rule ) because the Company failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the Form 10-Q ) with the Securities and Exchange Commission ( SEC ). The Notice has no immediate effect on the listing or trading of the Company s securities on the Nasdaq Capital Market.
Share this article
Share this article
ST. PETERSBURG, Fla., March 2, 2021 /PRNewswire/ Isleworth Healthcare Acquisition Corp. (NASDAQ: ISLEU) (the Company ) announced today the closing of its initial public offering of 20,700,000 units, which included the full exercise of the underwriters over-allotment option, at a price to the public of $10.00 per unit. The units began trading on the Nasdaq Capital Market under the symbol ISLEU on February 25, 2021.
Each unit consists of one share of common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the common stock and warrants are expected to be traded on the Nasdaq Capital Market under the symbols ISLE and ISLEW, respectively.